Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial sponsored by Hoffmann-La Roche is evaluating the efficacy and safety of multiple targeted therapies for non-small cell lung cancer; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING